Literature DB >> 19574488

Inclusion bodies in tick-borne diseases diagnosed in patients from northern Wisconsin.

Mrinal M Patnaik1.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19574488      PMCID： PMC2705270          DOI： 10.3121/cmr.2009.807.818

Source DB:  PubMed          Journal:  Clin Med Res        ISSN： 1539-4182


× No keyword cloud information.
  9 in total

1.  Roles of the Maltese cross form of Babesia microti in the development of parasitemia in B. microti infection.

Authors:  Tomás Camacho
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

2.  Serial measurements of hematologic counts during the active phase of human granulocytic ehrlichiosis.

Authors:  J S Bakken; M E Aguero-Rosenfeld; R L Tilden; G P Wormser; H W Horowitz; J T Raffalli; M Baluch; D Riddell; J J Walls; J S Dumler
Journal:  Clin Infect Dis       Date:  2001-03-07       Impact factor: 9.079

3.  The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America.

Authors:  Gary P Wormser; Raymond J Dattwyler; Eugene D Shapiro; John J Halperin; Allen C Steere; Mark S Klempner; Peter J Krause; Johan S Bakken; Franc Strle; Gerold Stanek; Linda Bockenstedt; Durland Fish; J Stephen Dumler; Robert B Nadelman
Journal:  Clin Infect Dis       Date:  2006-10-02       Impact factor: 9.079

Review 4.  Human babesiosis: an emerging tick-borne disease.

Authors:  A M Kjemtrup; P A Conrad
Journal:  Int J Parasitol       Date:  2000-11       Impact factor: 3.981

5.  Atovaquone and azithromycin for the treatment of babesiosis.

Authors:  P J Krause; T Lepore; V K Sikand; J Gadbaw; G Burke; S R Telford; P Brassard; D Pearl; J Azlanzadeh; D Christianson; D McGrath; A Spielman
Journal:  N Engl J Med       Date:  2000-11-16       Impact factor: 91.245

Review 6.  Anaplasma and Ehrlichia infection.

Authors:  J Stephen Dumler
Journal:  Ann N Y Acad Sci       Date:  2005-12       Impact factor: 5.691

7.  Antibiotic susceptibilities of Anaplasma (Ehrlichia) phagocytophilum strains from various geographic areas in the United States.

Authors:  Max Maurin; Johan S Bakken; J Stephen Dumler
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

8.  Roles of the Maltese cross form in the development of parasitemia and protection against Babesia microti infection in mice.

Authors:  Naoaki Yokoyama; Sabine Bork; Mitsuhiro Nishisaka; Haruyuki Hirata; Tomohide Matsuo; Noboru Inoue; Xuenan Xuan; Hiroshi Suzuki; Chihiro Sugimoto; Ikuo Igarashi
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

Review 9.  Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment.

Authors:  J Stephen Dumler; John E Madigan; Nicola Pusterla; Johan S Bakken
Journal:  Clin Infect Dis       Date:  2007-07-15       Impact factor: 9.079
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.